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Abstract 
Background: Autonomic impairment after acute traumatic brain injury (TBI) has been associated 
independently with both increased morbidity and mortality. Links between autonomic impairment 
and increased intracranial pressure (ICP) or impaired cerebral autoregulation (PRx) have been 
described as well.  However, relationships between autonomic impairment, ICP, PRx and outcome 
remain poorly explored. Using continuous measurements of heart rate variability (HRV) and 
baroreflex sensitivity (BRS) we aimed to test whether autonomic markers are associated with 
functional outcome and mortality independently of intracranial variables.  Further, we aimed to 
evaluate the relationships between autonomic functions, ICP and cerebral autoregulation.  
Methods: Waveforms of ICP and arterial blood pressure (ABP) were collected in TBI patients 
admitted to a single neurocritical care unit. Baseline Glasgow Coma Scale (GCS) and 6 months 
Glasgow Outcome Scale (GOS) were recorded. BRS was assessed every 10s using a modified cross-
correlational method. Frequency domain analyses of HRV were performed automatically every 10 
seconds from a moving 300s of the monitoring time window. Mean values of BRS, HRV, ICP, ABP, 
cerebral perfusion pressure (CPP) and PRx over the entire monitoring period were calculated for each 
patient.  
 
Results: 262 patients with median age 36 years entered the analysis. The median admission GCS was 
6, the median GOS was 3, mortality at 6 months was 23%.  BRS (adjusted OR 0.9, p=0.02) and relative 
power of HF band of HRV (adjusted OR 1.05, p<0.001), were individually associated with mortality 
independently of age, admission GCS, ICP, PRx or CPP. BRS showed no correlation with ICP, or CPP,   
the correlation with PRx was strong in older patients (age>60). Relative power of HF correlated 
significantly with ICP and CPP, but not with PRx. Relative powers of LF correlated significantly with 
PRx.  
Conclusion: Autonomic impairment as measured by HRV and BRS is significantly associated with 
increased mortality after TBI. These effects, though partially interlinked, seem to be independent of 
age, trauma severity, ICP or autoregulatory status, and thus represent a discrete phenomenon in the 
pathophysiology of TBI. Continuous measurements of HRV and BRS in the neuromonitoring setting of 
severe TBI may carry novel pathophysiological and predictive information. 
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Introduction 
In acute brain injury, decreased heart rate variability (HRV) and decreased baroreflex sensitivity (BRS) 
are thought to mirror central impairment in coupling between the autonomic and cardiovascular 
systems. The baroreflex is the main neural mechanism  that compensates spontaneous fluctuations 
in blood pressure and is under full influence of the central autonomic regulation.  Suppression of this  
regulatory system may be caused by impairment of the central processing, and in traumatic brain 
injury may be a consequence of primary damage or due to the induced stress reaction.(1, 2) 
Several studies have observed autonomic changes in patients suffering traumatic brain injury (TBI) by 
assessing HRV and BRS. These changes are thought to be related to the severity of injury and, more 
importantly, seem to correlate with increased morbidity and mortality. (3-6)   Associations of 
autonomic system changes with increased intracranial pressure (ICP) have been suggested as well.(3, 
4, 7) However, relationships between autonomic impairment, intracranial physiology and outcome 
remain unclear.  None of the previous studies adjusted their outcome analyses for intracranial 
factors like ICP or the state of cerebral autoregulation, which are both important predictors of 
outcome in TBI.(8-10)  
The autonomic nervous system in acute brain injured patients is also influenced by numerous factors 
of clinical management. These include sedation, analgesia, vasopressors, inotropes, mechanical 
ventilation and nursing procedures and create an “ICU noise” that represents an incalculable 
combination of confounding variables. Most of the previous studies have thus tried to minimise 
these confounding factors by excluding patients on cardiovascular drugs or on sedatives and using 
intermittently sampled HRV or BRS. However, when exploring the potential of real-time monitoring 
autonomic function in TBI patients, one has to consider not only the highly dynamic nature of the 
disease but also the inherent complex clinical interventions.  
The primary aim of our study was to test the hypothesis that changes in continuously monitored 
autonomic function are associated with functional outcome after TBI independent of intracranial 
physiology (ICP and cerebral autoregulation) and despite the inherent and unpredictable “ICU noise”. 
The secondary aim was to elucidate the relationships between continuously measured autonomic 
functions, ICP and cerebral autoregulation.   
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Methods  
Subjects 
Data from 327 TBI patients admitted to the neurocritical care unit of the Addenbrooke’s Hospital, 
Cambridge University between 2003-2009 and undergoing multimodal monitoring including arterial 
blood pressure (ABP) and intracranial pressure (ICP) were analyzed retrospectively. All patients were 
sedated, intubated, and received mechanical ventilation during the whole recording period. A 
cerebral perfusion pressure (CPP)- and ICP-oriented protocol for management of head injury was 
followed, with CPP maintained at > 60 mm Hg and ICP < 20–25 mm Hg.(11) Baseline neurological 
status of each patient was determined using the Glasgow Coma Scale (GCS) score on admission. In 
patients who were deemed too unstable to undergo formal neurological assessment on admission, 
the GCS score collected on scene was used. The clinical outcome was assessed at 6 months by using 
the Glasgow Outcome Scale (GOS).(12) Primary outcome measure was mortality at 6 months (GOS 
1). Secondary outcome measures were poor outcome, defined as GOS dead and persistent 
vegetative state (GOS 1 and 2) and unfavorable outcome defined as GOS dead, persistent vegetative 
state and severe disability (GOS 1, 2 and 3).  All monitoring modalities recorded in the study were 
part of the standard clinical care.  
Data Acquisition and Processing 
ABP was monitored invasively through the radial or femoral artery with the aid of a standard 
pressure monitoring kit (Baxter Healthcare, CardioVascular Group) and was zeroed at the level of the 
right atrium. ICP was monitored using an intraparenchymal probe (Codman ICP MicroSensor, 
Codman & Shurtleff) inserted into the frontal cortex. All signals were digitized using an analog-to- 
digital converter (DT9801, Data Translation), sampled at a frequency of 100 Hz, and recorded using a 
laptop computer with ICM+® software (Cambridge Enterprise, Cambridge, UK, 
http://www.neurosurg.cam. ac.uk/icmplus). The same software was later used for the retrospective 
analysis of all stored signals. Time-averaged values of ICP, ABP, and CPP (CPP = ABP – ICP) were 
calculated using waveform time integration over 60-second intervals. Cerebral autoregulation was 
monitored using the pressure reactivity index (PRx), calculated as a moving Pearson correlation 
coefficient between changes in 30 consecutive 10-second averages of ABP and corresponding ICP 
signals (with 80% overlap of data). Averaging over 10 seconds was used to suppress the influence of 
pulse and respiratory waves. 
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Heart rate variability 
According to the international guidelines on HRV analysis(13), we used parameters from time and 
frequency domain analysis. For all HRV parameters we used 300s time series of RR intervals updated 
every 10s. In the time domain we calculated standard deviation (SD), standard deviation of the 
difference between sequential beats (SDSD), and square root of the mean squared difference 
between sequential beats (RMSSD). In the frequency domain we used Lomb-Scargle periodogram to 
calculate spectral power of RR time series in the low frequency range (LF: 0.04-0.15Hz), the high 
frequency range (HF: 0.15-0.4Hz), the total power (TP: 0.04-0.4Hz) and the LF/HF ratio. Further, for 
HF and LF, relative (ratio of the components power divided by the sum of HF, LF and VLF components 
total power) powers were calculated.  
Baroreflex sensitivity 
Baroreflex sensitivity (BRS) was calculated using a modification of the sequential cross-correlation 
method. (14) The modified function uses arterial blood pressure systolic peaks to create RR intervals 
time series, using an automated detection algorithm. The slope of the linear regression between 10s 
series of RR intervals and the corresponding 10s series of systolic blood pressure is then calculated. 
In order to remove the influence of an unknown time delay of the baroreceptor response, a cross-
correlation function is used to maximize the correlation coefficient. The RR window is shifted against 
the systolic pressure window in a stepwise manner and the highest correlation is reported, if it fulfils 
the criteria outlined below. In order to ensure that the correlation calculations are always performed 
on the same number of data points irrespective of the lag applied to RR series, the actual data buffer 
is extended with each window shift. Valid BRS value is returned only if the correlation coefficient is 
significant at p<0.01, and if no irregular beats (ectopics) are detected by the software. To 
compensate for the influence of uncorrelated noise the slope returned is adjusted (divided by) the 
correlation coefficient. The BRS is updated every 10s and expressed in ms/mmHg. 
 
 
Statistics 
The data are presented as median values, range and interquartile range. The nonparametric 
Wilcoxon rank-sum test was used to compare medians across the outcome categories (mortality, 
poor outcome or unfavorable outcome). Nonparametric Spearman correlations and associated p-
values were used to correlate patient average values of HRV parameters, BRS, ICP, CPP, and PRx. For 
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outcome analysis, one mean value of the variables HRV, BRS, PRx, CPP, and ICP was calculated for 
each patient (mean over the entire monitoring period). The effect of “classical” predictors (age, 
admission GCS, ICP, CPP, PRx) and/or autonomic variables on outcome was investigated by logistic 
regression models. For each independent variable, intuition for the degree of its adjusted effect on 
the outcome was obtained from crude restricted cubic splines (with the number of knots varying 
from 3 to 5) and a formal hypothesis test for linearity. The best subset selection algorithm was 
applied. This is an exhaustive method that searches the best model, based on the lowest Akaike 
Information Criterion (AIC), among those obtained from all possible subsets of independent 
variables.  Comparison between nested models was also performed with the log-likelihood ratio test. 
The area under the ROC curve was used as a measure of the discrimination ability of a model. 
Statistical analyses were performed using the SPSS version 19 software and the R language and 
software environment for statistical computation, version 2.12.1(15) The significance level was set at 
0.05.  
 
Ethics 
Data collection and analysis has been approved by the Neurocritical Care Users’ Committee and the 
Research Ethics Committee (29 REC 97/291).   
Results 
Population 
327 consecutive severe TBI patients were screened for the entry into the study.  53 patients were 
excluded because of incomplete outcome data. Further 10 patients were excluded because of 
artifacts in the HRV and BRS analysis mainly due to atrial fibrillation or other arrhythmias, leaving 
thus 262 patients in the final dataset.  Excluded patients did not differ significantly in age, median 
GCS, median GOS, median ICP, median CPP or median PRx from those included in the final dataset 
(data not shown). The median age of the patients was 36 years (range 16-76.4, IQR 25), 141 (53.8%) 
were male, median GCS was 6 (range 3-15, IQR 5), median GOS at 6 months was 3 (range 1-5, IQR 2). 
Six (2.3%) patients underwent primary decompressive craniectomy, 19 (7.2%) underwent secondary 
decompressive craniectomy. Median ICP was 16.1 mm Hg (3-51, IQR 6.3), median CPP was 77.2 mm 
Hg (56-102, IQR 7.6) and median PRx was 0.07 (-0.3 – 0.7, IQR 0.2). Mean  SD monitoring duration 
was 154.34 hours +/- 126.3 hours (Q1 = 49.5 hours, Q3 = 218.5 hours, IQR = 169 hours). The 
respective percentage of data availability as a function of the total monitoring duration were: arterial 
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blood pressure 92.4% (SD 12), heart rate 90.4% (SD 14), ICP 91.9% (SD 15), CPP 86.8% (SD 18), PRx 
86.3% (SD 18), BRS 48.7% (SD 20.1), relative power of HF 90.8% (SD 13.8), relative power of LF 89.1% 
(SD 19) and LF/HF ratio 90.72% (SD 14). Example of time trends from one patient is shown in Figure 
1. 
 
Outcome and mortality 
Mortality at 6 months in the group of patients included in the analysis was 23.3%. Poor outcome was 
reached in 67 patients (25.6%) and unfavorable outcome in 149 patients (56.9%).  For the univariate 
comparison of clinical and autonomic variables between survivors and non-survivors see Table 1. 
Among the “classical” predictors, statistically significant differences between the survivors and non-
survivors were identified for all variables but GCS (p=0.072). As for the autonomic variables, the LF 
total power (p=0.833), the LF relative power (p=0.137) and the HRV total power (p=0.701) failed to 
have statistically significant different medians across survivors and non-survivors (Table 1).  
Firstly, the model considering only the “classical” predictors was calculated. For mortality and poor 
outcome, the whole predictor was found to be linear in age, admission GCS and PRx and to be 
quadratic in ICP (Table 2). Compared to a linear effect, the quadratic effect of ICP produced greater 
probabilities for mortality within the high range of ICP values. The variable CPP was not found to 
have a statistically significant (adjusted) effect (p=0.616 for mortality; p=0.197 for poor outcome). 
The model for the unfavorable outcome was linear in age, GCS and ICP and has failed to identify 
significant effects for CPP (p=0.800) and PRx (p=0.124), see Table 2. 
Subsequently, the model considering simultaneously all predictors, “classical” and autonomic, was 
explored. The number of independent variables constrained all effects to be linear. Among all 
possible subsets of predictors, the model with the lowest AIC identified age, GCS, PRx, ICP, BRS and 
relative power of HF as the variables with a statistically significant effect on mortality (Table 3). For 
the poor outcome, the best-AIC logistic regression model identified the same statistically significant 
predictors as the model for mortality (Table 3). The chosen model for the unfavorable outcome 
extended the classical model from before, adding relative and total HF power (Table 3). 
The area under the ROC curve (AUC) obtained for the best mortality, poor outcome and unfavorable 
outcome models was 0.844, 0.824 and 0.771, respectively, showing that the models exhibited a good 
discrimination ability.  
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Autonomic parameters, age and GCS 
Age correlated weakly with the relative HF powers (r=-0.17, p=0.01) and with relative LF powers 
(r=0.13, p=0.03). GCS showed no significant correlations with any of the autonomic parameters.  
 
Autonomic parameters and ICP, CPP and PRx 
ICP correlated well with relative HF power (r=0.34, p<0.001), with relative LF power (r=-0.29, 
p<0.001) and with LF/HF ratio (r=-0.38, p<0.0001). CPP correlated with relative HF powers (r=-0.33, 
p<0.001), weakly with relative LF powers (r=0.14, p=0.02) and well with LF/HF ratio (r=0.34, p<0.001). 
PRx correlated weakly only with relative power of LF (r=0.18, p=0.01).  On the whole, BRS showed no 
significant correlations with intracranial variables, see also Figure 2 and Figure 3. However, there was 
a strong age-dependent trend towards higher correlation coefficients between PRx and BRS (up to 
0.76), reaching significance in the elderly (above 60 years), see Figure 4. 
 
Discussion  
In our group of sedated and ventilated patients with severe brain trauma there was a significant 
association of both low baroreceptor sensitivity and decreased heart rate variability with higher 
mortality and poor outcome. We also found evidence of increased parasympathetic activity 
(increased HF powers) and decreased LF/HF ratio in non-survivor and those with poor outcome.  
These continuously monitored indicators of autonomic function seem to be linked to TBI outcome 
independently of age, initial trauma severity, ICP levels or autoregulatory status raising the future 
prospect of autonomic nervous system targeted therapy. 
Our results are consistent with findings from previous studies. In classical studies by Wintchell (5) and 
Biswas in children(3) a decrease in LF/HF  ratio was also reported. A study by Kox with severe brain 
injury patients requiring intensive care showed concordantly higher HF powers and lower LF/HF ratio 
as compared to healthy volunteers. (16) Goldstein et al observed decreased RR interval variability, 
decreased LF powers of HRV and BP in a case mix of brain injury nonsurvivors.(17) Another TBI series 
found low BRS, low RR variability and a decrease in LF/HF ratios in nonsurvivors from TBI. (2) 
However what is unique about our findings, is that none of the previous studies adjusted for ICP or 
CPP effects, despite several former reports underlining associations between increased 
ICP/decreased CPP and autonomic changes.(3, 5, 7, 18) Thus, based on the presented results it seems 
that despite being correlated with ICP or CPP, the autonomic changes may have additive, 
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independent, associations with TBI outcome. Furthermore, the results also suggest that autonomic 
changes are linked to worse outcome independently of the cerebral autoregulatory status.  In terms 
of clinical interpretation of the model, for every unit increase in baroreflex sensitivity the odds for 
mortality is expected to decrease by 11.2%. For every unit increase in relative HF power the odds for 
mortality is expected to increase by 4.6%.  
Higher HF powers and lower LF/HF ratios in non-survivors may indicate principally an increased vagal 
and decreased sympathetic activity in patients with poor outcome.  The HF power is believed to 
reflect cardiac parasympathetic activity while the LF power, although much more complex, is often 
assumed to have a dominant sympathetic component. Logically, LF/HF ratio is then suggested to 
mirror sympatho-vagal balance. However, mounting evidence indicates that these assumptions are 
naïve and oversimplified given the complex non-linear interactions between the sympathetic and the 
parasympathetic systems. (19-22) This holds particularly true for the interpretation of LF power as 
the main component of cardiac sympathetic regulation.  The LF component seems rather to reflect a 
mix of sympathetic, parasympathetic, and unidentified factors and furthermore parasympathetic 
factors may account for a significant proportion of the variability. (22) As a consequence, the LF/HF 
ratio is problematic to interpret as well.  Some authors consider the LF powers of HRV to represent 
baroreflex activity. (23)   Consistent with this theory, LF powers correlated with BRS (r=0.41, p<0.001, 
data not shown). Overall, TBI nonsurvivors and those with poor outcome in our study seem to exhibit 
relatively increased vagal activity and decreased baroreflex sensitivity. But whether or not the 
sympathetic activity is significantly affected, reduced relatively or absolutely, remains speculative.   
How autonomic changes contribute to poor TBI outcome remains hypothetical.  Increased vagal 
activity may exert immunosuppressive effects through the cholinergic anti-inflammatory 
pathway(24) resulting in increased susceptibility to infections and sepsis after TBI. Indeed, increased 
rates of infections and sepsis have been observed after TBI. (25, 26) The immune response after TBI 
seem to be severely impaired  including decreased T-helper and NK-cell activity and reduced 
production of TNFa, IL-1b, IL-6,IL-8, IFNg and IL-12. (25, 27) Decreased baroreflex sensitivity mirroring  
probably more complex autonomic changes involving both the parasympathetic and sympathetic 
arms has been linked to cardiovascular complications and cardiac death, insulin resistance and 
hyperglycemia, brain edema formation or immunosuppression.(28, 29) All these factors may 
potentially contribute to secondary brain injury after TBI and worse outcome.  Thus, as has already 
been proposed in other types of acute brain injury (28, 30), the current data raises the possibility of 
autonomic impairment as a future therapeutic target in TBI.  
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Our outcome analysis inevitably focused on single (per patient), averaged, measurements. However, 
given the significant and consistent results achieved here, one can in the future explore the time 
evolution of the autonomic system impairment/recovery in the context of development of secondary 
insults in the acute phase of severe brain trauma treatment. In our cohort we were able to calculate 
valid BRS and HRV values making them potential candidate for real-time trending alongside vital 
signs and the cerebral autoregulation index. Perhaps, similiarly to cerebral autoregulation, or in 
relation with it, one can use the continually updated status of the autonomic system to offer 
individualised thresholds for critical care management.   
 
Limitations 
In contrast to previous studies, which used selected short-term HRV measurements, free of 
interventions and confounding medication, we used long-term indiscriminate averaging of the HRV 
and BRS indices. Our presumption was that, ultimately, the brain injury induced profound 
impairment in the autonomic regulation would outweigh the transient changes inherent and 
inseparable from the critical care environment such as changes in body temperature, body position 
changes, volume status, respiratory rate and tidal volume, nursing manoeuvres, ambient noise, 
critical illness/complications and last but not least alterations in the medical therapy.(31) 
Reassuringly, we were able to reproduce the general findings of the previous studies.  Of course, one 
cannot exclude the possibility that some measurements were skewed by the ‘ICU bias’ in the same 
direction, therefore mimicking results consistent with the previous literature, however, we consider 
this probability as low.  Nevertheless, this indiscriminate approach has to be considered as a major 
limitation of our study.   
However, given our congruent results, and the potentially added value of trending the autonomic 
system in real time we feel that the benefits of this approach outweigh its limitations. Our study has 
strengths including the prospective and standardized collection of physiological, clinical and outcome 
data, relative high number of subjects and uniform group including exclusively TBI patients. In 
comparison, previous studies used short, one time-point measurements in low a number of subjects 
(n usually around 20), were retrospective in its nature and included a case mix of brain injury patients 
with various etiologies.  
 
Conclusion 
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Long-term continuous measurement of autonomic parameters as BRS and HRV in the neurocritical 
care setting is feasible and may provide valuable additive physiological and prognostic information. In 
severe TBI deterioration in measures of the autonomic functions seems to offer an independent 
value in its association with poor outcome. The nature of links between autonomic dysfunction and 
outcome is so far underexplored. However, given the importance of autonomic changes for TBI 
outcome, optimizing the autonomic function may perhaps be considered a future therapeutic target 
in brain injury. 
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Figure 1:  Example of time trends of intracranial and autonomic variables for one patient as sampled by one 
minute. 
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Figure 2: Association between selected HRV parameters, BRS and ICP. With increasing ICP, relative HF power 
increases and relative LF power decreases. Analogous, LF/HF ratio decreases. BRS shows no significant changes.  
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Figure 3: Association between selected HRV parameters, BRS and CPP. With decreasing CPP, relative HF power 
increases and relative LF power decreases. Analogous, LF/HF ratio decreases. There is a trend toward lower BRS 
with decreased CPP.  
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Figure 4. Relation between age and Spearman r for the BRS- PRx correlation.  
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Table 1. Comparison of clinical and autonomic variables between TBI survivors and non-survivors at 6 months. 
 
 Survivors, n=201 Non-survivors, n=61 p-value 
Age, years, median (range, IQR) 33 (16-76, 23) 44 (18-76, 32) <0.001 
GCS, median (range, IQR) 7 (3-15, 6) 5 (3-14, 5) 0.072 
ICP, mmHg, median (range, IQR) 15.8 (4.5-29.0, 5.6) 17.6 (3.0-50.9, 9.7) 0.002 
CPP, mmHg, median (range, IQR) 77.7 (57.7-100.1, 6.6) 74.2 (56.2-102.1, 11.6) 0.002 
 PRx, median (range, IQR)  0.05 (-0.29-0.70, 0.20) 0.14 (-0.30-0.70, 0.23) 0.002 
BRS, ms/mmHg, median (range, IQR) 6.6 (1.6-18.8, 4.2) 5.1 (1.3-18.7, 4.0) 0.026 
HF power, ms2, median (range, IQR) 160.0 (9.9-1853.9, 285.4) 115.0 (6.2-1840.3, 212.1) 0.024 
HF relative power, median (range, IQR) 25.8 (5.0-65.4, 17.5) 33.4 (6.6-81.8, 22.3) <0.001 
LF/HF ratio, median (range, IQR) 1.6 (0.2-8.3, 1.3)  1.0 (0.0-8.8, 1.2) <0.001 
LF power, ms2, median (range, IQR) 598 (9-133927, 1883) 748 (1-41628, 2291) 0.833 
LF relative power, median (range, IQR) 22.1 (7.7-39.5, 7.5) 19.9 (2.6-45.7, 12.1) 0.137 
HRV total power, ms2, median (range, IQR) 2551 (90-250617, 3802) 2169 (56-66197, 4228) 0.701 
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Table 2 . Multiple logistic regression models to predict outcome at 6 months including “classical” predictors 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Mortality at 6 months Poor outcome at 6 month  
(GOS 1,2) 
Unfavorable outcome at 6 months  
(GOS 1-3) 
    
 Adj OR 95% CI p-value Adj OR 95% CI p-value Adj OR 95% CI p-value 
Age 1.061 1.036-1.087 <0.001 1.057 1.034-1.081 <0.001 1.057 1.037-1.078 <0.001 
Admission GCS 0.821 0.733-0.919 0.001 0.820 0.736-0.914 <0.001 0.817 0.749-0.892 <0.001 
ICP, mmHg 0.699 0.507-0.965 0.030 0.745 0.549-1.012 0.060 1.103 1.044-1.167 0.001 
ICP2, mmHg2 1.015 1.005-1.024 0.002 1.013 1.004-1.021 0.005 ----- ----- ----- 
PRx 12.879 1.668-99.423 0.014 7.314 1.048-51.032 0.045 ----- ----- ----- 
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Table 3. Multiple logistic regression models to predict mortality at 6 months including “classical” and 
autonomic variables.  
 
 Adj OR 95% CI p-value 
Model for mortality 
BRS, ms/mmHg 0.888 0.801-0.984 0.024 
HF relative power, ms2 1.046 1.019-1.074 0.001 
Age 1.073 1.046-1.101 <0.001 
Admission GCS 0.800 0.713-0.899 <0.001 
 ICP, mmHg 1.140 1.062-1.225 <0.001 
PRx 11.927 1.559-91.254 0.017 
 
 
 
   
Model for poor outcome 
BRS 0.887 0.804-0.978 0.016 
HF relative power, ms2 1.041 1.015-1.068 0.002 
Age 1.068 1.043-1.095 <0.001 
Admission GCS 0.802 0.718-0.897 <0.001 
 ICP, mmHg 1.132 1.058-1.211 <0.001 
PRx 7.317 1.041-51.420 0.045 
    
Model for unfavorable outcome    
HF relative power, ms2 1.027 1.003-1.051 0.030 
HF power, ms2 0.999 0.998-1.000 0.061 
Age 1.058 1.037-1.080 <0.001 
Admission GCS 0.811 0.741-0.888 <0.001 
 ICP, mmHg 1.079 1.017-1.144 0.012 
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